Tech Company Financing Transactions
BillionToOne Funding Round
On 12/15/2022, BillionToOne secured $83.5 million in Series C funding from Adams Street Partners, Baillie Gifford and Bridge Bank.
Transaction Overview
Company Name
Announced On
12/15/2022
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$83,500,000
Round
Series C
Investors
Proceeds Purpose
These funds will be used to continue to scale UNITY Screen�, the only commercially available non-invasive prenatal test (NIPT) that assesses fetal risk for recessive conditions and red blood cell antigen incompatibility,
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1035 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
BillionToOne's mission is to make prenatal testing safe and affordable for every expecting mother. More than 3,000,000 babies are born with serious genetic defects in the world every year. BillionToOne's novel technology can detect even single-gene disorders such as thalassemia through a simple blood test.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Oguzhan Atay
Chief Financial Officer
Nipun Soni
Chief Technical Officer
David TSAO
VP - Operations
Brent Kirk
VP - Product Management
Shan Riku
VP - Sales
Nancy Johnson
Browse more venture capital transactions:
Prev: 12/15/2022: Poolit venture capital transaction
Next: 12/15/2022: Smarttech247 venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs